The Role of Public Sector Agencies in Contraceptive Research and Development
Until recently, contraceptive product development, the translation of a research finding into a final product, was successfully carried out by profit-making, commercial pharmaceutical companies. Interaction between commercial companies, scientists, and drug-regulatory agencies has defined the steps necessary for development of a safe, acceptable, and economically feasible product. Expected financial returns from sales of the final product have driven the development process.
KeywordsEstrogen Marketing Assure Propranolol Egypt
Unable to display preview. Download preview PDF.
- 1.Editorial (1980) Key findings highlight diversity. People 7:5Google Scholar
- 3.Wahren C (1984) The role of industry, agencies and governments in research on fertility regulation: past experience and future prospects. In: Diczfalusy A, Diczfalusy E (eds) Research on the regulation of human fertility. Scriptor, CopenhagenGoogle Scholar
- 4.UN General Assembly (1981) The least developed countries in the 1980s. UN conference on the least developed countries, A/CONF. 104/4 Add.lGoogle Scholar
- 5.UNFPA (1981) Family planning in the 1980s: challenges and opportunities. Report of the International Conference on Family Planning in the 1980s, Jakarta. New York: Population Council, New YorkGoogle Scholar
- 6.Buckles RG (1979) Contraceptive product development in public-sector programmes. PIACT paper 3Google Scholar
- 8.PIACT. NORPLANT® (1981) Instructions for cliniciansGoogle Scholar
- 11.Enever RP, Lewis GA (1983) The influence of pharmaceutical formulation upon biological activity of esters of norethisterone. Steroids 41:359Google Scholar